Microvascular alterations in diabetic mice correlate with level of hyperglycemia

被引:56
作者
Algenstaedt, P
Schaefer, C
Biermann, T
Hamann, A
Schwarzloh, B
Greten, H
Rüther, W
Hansen-Algenstaedt, N
机构
[1] Univ Hamburg, Hosp Eppendorf, Dept Orthopaed Surg, D-20246 Hamburg, Germany
[2] Univ Hamburg, Hosp Eppendorf, Dept Internal Med, D-20246 Hamburg, Germany
[3] Univ Hamburg, Hosp Eppendorf, Ctr Biomech, D-20246 Hamburg, Germany
[4] Univ Heidelberg Hosp, Dept Internal Med 1, Heidelberg, Germany
关键词
D O I
10.2337/diabetes.52.2.542
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular alterations are the most common causes of morbidity and mortality in diabetic patients. Despite the impact of endothelial dysfunction on microcirculatory properties, little is known about the endothelial cell alteration during the development of diabetes and its correlation to the metabolic situation. For that reason we continuously monitored in vivo functional and morphological alterations of the microvasculature in hyperglycemic and hyperinsulinemic transgenic UCP1/DTA mice with brown fat deficiency, using a dorsal skin-fold chamber preparation and fluorescence microscopy. UCP1/DTA mice showed a dramatic decrease in vascular density due to a remarkable reduction of small vessels. Vascular permeability and leukocyte endothelial interactions (LEIs) significantly increased. The extent of vascular alteration correlated with the extent of metabolic dysfunction. Decreased tissue perfusion observed in UCP1/DTA mice might play a role in impaired wound healing observed in diabetes. The increased permeability in subcutaneous tissue may serve as predictor of vascular changes in early stages of diabetes. The increased LEI and serum tumor necrosis factor-alpha levels, which mirror the inflammatory process, support the growing evidence of the inflammatory component of diabetic disease. The results suggest that anti-inflammatory strategies might be able to prevent vascular deterioration in early stages of diabetes. Further investigations are required to evaluate the benefit of such therapeutic strategies.
引用
收藏
页码:542 / 549
页数:8
相关论文
共 42 条
[1]  
Antonetti D A, 1999, Semin Ophthalmol, V14, P240, DOI 10.3109/08820539909069543
[2]   Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content - Vascular endothelial growth factor decreases occludin in retinal endothelial cells [J].
Antonetti, DA ;
Barber, AJ ;
Khin, S ;
Lieth, E ;
Tarbell, JM ;
Gardner, TW .
DIABETES, 1998, 47 (12) :1953-1959
[3]   Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin [J].
Booth, G ;
Stalker, TJ ;
Lefer, AM ;
Scalia, R .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (06) :E848-E856
[4]   A COMPARISON OF TUMOR AND NORMAL TISSUE MICROVASCULAR HEMATOCRITS AND RED-CELL FLUXES IN A RAT WINDOW CHAMBER MODEL [J].
BRIZEL, DM ;
KLITZMAN, B ;
COOK, JM ;
EDWARDS, J ;
ROSNER, G ;
DEWHIRST, MW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 25 (02) :269-276
[5]   Mechanisms of angiogenesis and arteriogenesis [J].
Carmeliet, P .
NATURE MEDICINE, 2000, 6 (04) :389-395
[6]  
CHEUNG, 2001, ENDOCR PRACT, V7, P358
[7]   Improvements in diabetic microangiopathy after successful simultaneous pancreas-kidney transplantation: A computer-assisted intravital microscopy study on the conjunctival microcirculation [J].
Cheung, ATW ;
Perez, RV ;
Chen, PCY .
TRANSPLANTATION, 1999, 68 (07) :927-932
[8]   Role of growth factors in the development of diabetic complications [J].
Chiarelli, F ;
Santilli, F ;
Mohn, A .
HORMONE RESEARCH, 2000, 53 (02) :53-67
[9]   Cardiovascular abnormalities in transgenic mice with reduced brown fat - An animal model of human obesity [J].
Cittadini, A ;
Mantzoros, CS ;
Hampton, TG ;
Travers, KE ;
Katz, SE ;
Morgan, JP ;
Flier, JS ;
Douglas, PS .
CIRCULATION, 1999, 100 (21) :2177-2183
[10]   Tumor necrosis factor-α in sera of obese patients:: Fall with weight loss [J].
Dandona, P ;
Weinstock, R ;
Thusu, K ;
Abdel-Rahman, E ;
Aljada, A ;
Wadden, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (08) :2907-2910